The potential economic consequences of cognitive improvement with losartanJÖNSSON, Linus; GERTH, William; FASTBOM, Johan et al.Blood pressure. 2002, Vol 11, Num 1, pp 46-52, issn 0803-7051Article

Variability in stream macroinvertebrates at multiple spatial scalesLI, Judith; HERLIHY, Alan; GERTH, William et al.Freshwater biology (Print). 2001, Vol 46, Num 1, pp 87-97, issn 0046-5070Article

Restoring migraine sufferers' ability to function normally: A comparison of rizatriptan and other triptans in randomized trialsBUSSONE, Gennaro; D'AMICO, Domenico; MCCARROLL, Kathleen A et al.European neurology. 2002, Vol 48, Num 3, pp 172-177, issn 0014-3022Article

Productivity cost benefit to employers of treating migraine with rizatriptan: A specific worksite analysis and modelGERTH, William C; SARMA, Syam; HU, X. Henry et al.Journal of occupational and environmental medicine. 2004, Vol 46, Num 1, pp 48-54, issn 1076-2752, 7 p.Article

Macroinvertebrate community response to natural and forest harvest gradients in western Oregon headwater streamsHERLIHY, Alan T; GERTH, William J; LI, Judith et al.Freshwater biology (Print). 2005, Vol 50, Num 5, pp 905-919, issn 0046-5070, 15 p.Article

Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classesCONLIN, Paul R; GERTH, William C; FOX, James et al.Clinical therapeutics. 2001, Vol 23, Num 12, pp 1999-2010, issn 0149-2918Article

Burden of hospitalization of patients with Candida and Aspergillus infections in AustraliaSLAVIN, Monica; FASTENAU, John; SUKAROM, Isaya et al.International journal of infectious diseases. 2004, Vol 8, Num 2, pp 111-120, issn 1201-9712, 10 p.Article

Caspofungin versus amphotericin B for candidemia : A pharmacoeconomic analysisWINGARD, John R; WOOD, Craig A; SULLIVAN, Elizabeth et al.Clinical therapeutics. 2005, Vol 27, Num 6, pp 960-969, issn 0149-2918, 10 p.Article

Treatment outcomes in patients receiving conventional amphotericin B therapy : a prospective multicentre study in TaiwanCHEN, Chien-Yuan; KUMAR, Ritesh N; FENG, Yin-Hsun et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 57, Num 6, pp 1181-1188, issn 0305-7453, 8 p.Article

Losartan reduces the costs associated with diabetic end-stage renal disease: The RENAAL study economic evaluationHERMAN, William H; SHAHINFAR, Shahnaz; CARIDES, George W et al.Diabetes care. 2003, Vol 26, Num 3, pp 683-687, issn 0149-5992, 5 p.Article

The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathyCARIDES, George W; SHAHINFAR, Shahnaz; DASBACH, Erik J et al.PharmacoEconomics (Auckland). 2006, Vol 24, Num 6, pp 549-558, issn 1170-7690, 10 p.Article